Clinical Trials List
Protocol NumberAPL-C-001-09
2013-05-01 - 2020-08-17
Phase III
Terminated3
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/19
Investigators and Locations
Co-Principal Investigator
- Chien-Yuan Chen Division of Hematology & Oncology
- MING YAO Division of Hematology & Oncology
- Sheng-chieh Chou Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Kuan-Der Lee Division of Hematology & Oncology
- 黃慈恩 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Chun-Yu Liu Division of Hematology & Oncology
- Liang-Tsai Hsiao Division of Hematology & Oncology
- Jyh-Pyng Gau Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
13 participants
-
Global
250 participants
